Albuminuria as a marker of arterial stiffness in chronic kidney disease patients

doi:10.5527/wjn.v4.i3.406

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 4, Issue 3

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (6109)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Tables (1-6) series.

Item

Count

PDF

363

WORD

268

HTML

2701

Tables (1-6)

221

Sum=3553

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

1028

Download

1528

Sum=2556

Jul 6, 2015 (publication date) through Jan 10, 2025

Times Cited of This Article

Times Cited (7)

Journal Information of This Article

Publication Name

World Journal of Nephrology

ISSN

2220-6124

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Clinical Trial Study

World J Nephrol. Jul 6, 2015; 4(3): 406-414
Published online Jul 6, 2015. doi: 10.5527/wjn.v4.i3.406

Table 1 Demographic and aortic stiffness indices characteristics

Patients characteristics	Study population	Patients with moderately increased albuminuria	Patients with severely increased albuminuria	P value
No	115	58	57	-
Age (yr)	52.6 ± 14.6	51.4 ± 14.4	54.2 ± 15.07	NS
Sex (M/F), (n)	76/39	39/19	37/20	NS
BMI (kg/m²)	30.9 ± 19.3	28.6 ± 4.5	33.9 ± 28.2	< 0.03
Smoking, n (%)	5	3	2	NS
pSBP (mmHg)	138.0 ± 14.2	139 ± 12.7	138.0 ± 15.5	NS
pDBP (mmHg)	84.2 ± 9.7	84.9 ± 10.7	82.6 ± 9.8	NS
pPP (mmHg)	57.9 ± 15.9	56.7 ± 15.1	59.4 ± 16.9	NS
cSBP (mmHg)	130.3 ± 14.6	130 ± 13.3	130.2 ± 16.5	NS
cDBP(mmH)	84.2 ± 9.7	84.9 ± 10.7	84.3 ± 8.6	NS
cPP (mmHg)	48.1 ± 17.6	47.9 ± 17.9	48.4 ± 17.8	NS
AIx (%)	21.1 ± 10.6	18.4 ± 10.0	24.5 ± 10.0	< 0.004
PWVc-f (m/sec)	8.7 ± 2.0	8.3 ± 2.0	9.1 ± 1.9	< 0.02
ACEIs, n (%)
(ramipril or quinapril)	100 (86)	56 (96)	44 (77)	NS
AT1 RB, n (%)
(valsartan or olmesartan)	20 (17.4)	9 (15.5)	11 (19.2)	NS
CCBs, n (%)	11 (9.5)	6 (10.3)	5 (8.7)	NS
Statins, n (%)	7 (6.08)	3 (5.1)	4 (7.01)	NS

Data are presented as mean value. M/F: Male/female; BMI: Body mass index; pSBP: Peripheral systolic blood pressure; pDBP: Peripheral Diastolic blood pressure; pPP: Peripheral pulse pressure; cSBP: Central systolic blood pressure; cDBP: Central diastolic blood pressure; cPP: Central pulse pressure; AIx: Augmentation index; AP: Augmentation pressure; PWVc-f: Pulse wave velocity carotid-femoral; ACEIs: Angiotensin converting enzyme inhibitors; AT1RB: Angiotensin type 1 receptor blockers; CCBs: Calcium channel blockers.

Table 2 Biochemical characteristics of the study population

Patients characteristics	Study population	Patients with moderately increased albuminuria	Patients with severely increased albuminuria	P value
No	115	58	57	-
Ht (%)	42.3 ± 3.7	43.2 ± 3.7	41.4 ± 3.5	0.01
Hb (g/dL)	13.6 ± 1.3	14.1 ± 1.5	13.3 ± 1.5	0.02
Fe (μg/dL)	89 ± 35.5	90.2 ± 30	84.2 ± 38.5	NS
Ferritin (ng/L)	127.4 ± 90.1	127.8 ± 87.9	131.3 ± 96.5	NS
Fibrinogen (mg/dL)	336 ± 82.9	339 ± 86.5	394 ± 133.9	< 0.01
hsCRP (mg/dL)	0.19 ± 0.06	0.18 ± 0.05	0.23 ± 0.10	< 0.001
T-CHOL (mg/dL)	203 ± 37.5	208 ± 39.2	209 ± 46.8	NS
TRG (mg/dL)	126 ± 45.7	123 ± 46.3	145 ± 70.2	0.05
HDL-C (mg/dL)	53.4 ± 13.3	53 ± 12.9	54.2 ± 14.9	NS
LDL-C (mg/dL)	119 ± 32	120 ± 3.7	121 ± 3.6	NS
Ca²⁺ (mg/dL)	9.7 ± 0.4	9.7 ± 0.5	9.8 ± 0.4	NS
PO₄^3- (mg/dL)	3.42 ± 0.4	3.3 ± 0.4	3.5 ± 0.5	0.01
Ca²⁺ x PO₄^3-	33.7 ± 4.8	32.6 ± 4.5	33.9 ± 8.6	NS
PTH (pg/mL)	42.4 ± 15.4	39.8 ± 13.6	45.4 ± 29.9	NS
sAlb (gr/dL)	4.5 ± 0.2	4.5 ± 0.3	4.3 ± 0.5	0.03
eGFR-MDRD (mL/min per 1.73 m²)
eGFR-MDRD (mL/min per 1.73 m²)	92 ± 0.5	91.5 ± 20.5	79.1 ± 15.3	< 0.001
CKD-EPI(mL/min per 1.73 m²)
CKD-EPI(mL/min per 1.73 m²)	73.4 ± 1.25	73.1 ± 13.7	73.6 ± 11.2	NS

Data are presented as mean value. Ht: Haematocrit; Hb: Haemoglobin; Fe: Serum iron; Ferritin: Serum ferritin, hsCRP: High sensitive C-reactive protein; T-CHOL: Total cholesterol; TRG: Triglycerides; HDL-C: High density lipoprotein cholesterol; Ca²⁺: Calcium; PO₄^3-: Phosphorus; PTH: Parathormone; sAlb: Serum albumin; eGFR-MDRD: Estimated-glomerular filtration rate-modification of diet in renal disease; RAAS-blocker: Renin angiotensin aldosterone system blocker; Alb: Albuminuria.

Table 3 Univariate linear regression analysis of the parameters associated with the absolute values of pulse wave velocity

Covariates	β	t	β(95%CI)	P value
Alb	0.841	2.271	0.107-1.574	< 0.025
Age	0.026	2.047	0.001-0.051	< 0.043
BMI	0.009	0.880	0.011-0.028	0.381
pSBP	0.032	2.511	0.007-0.058	< 0.013
pDBP	0.005	0.285	-0.032-0.042	< 0.776
pPP	0.029	2.277	0.004-0.053	< 0.025
cSBP	0.031	2.298	0.004-0.508	< 0.024
cDBP	-0.004	-0.173	-0.045-0.038	0.963
cPP	0.014	1.257	0.008-0.037	0.212
Ht	0.103	2.077	0.005-0.202	0.040
Hb	0.227	1.812	0.020-0.476	0.070
T-CHOL	0.021	0.456	-0.011-0.007	0.649
TRG	0.002	0.752	0.009-0.004	0.454
HDL-C	-0.006	-0.417	-0.033-0.022	0.677
LDL-C	0.023	0.445	0.013-0.477	0.674
Fbrinogen	0.0001	0.524	-0.004-0.002	0.602
hsCRP	-0.011	0.046	-0.442-0.422	0.964
RAAS-blocker	0.081	-0.103	-1.650-1.487	0.918

Alb: Albumin; BMI: Body mass index; pSBP: Peripheral systolic blood pressure; pDBP: Peripheral diastolic blood pressure; pPP: Peripheral pulse pressure; cSBP: Central systolic blood pressure; cDBP: Central diastolic blood pressure; cPP: Central pulse pressure; Ht: Haematocrit; Hb: Haemoglobin; T-CHOL: Total cholesterol; TRG: Triglycerides; HDL-C: High density lipoprotein cholesterol; RAAS-blocker: Renin angiotensin aldosterone system blocker; LDL-C: Low density lipoprotein cholesterol; hsCRP: HsC-reactive protein.

Table 4 Multivariate linear regression analysis of the parameters associated with the absolute values of pulse wave velocity

Covariates	β	t	β(95%CI)	P value
UAlb	1.038	2.638	0.257-1.820	< 0.010
pSBP	0.028	2.149	0.002-0.053	< 0.034
Ht	0.171	3.319	0.069-0.273	< 0.001

pSBP: Peripheral systolic blood pressure; Ht: Haematocrit.

Table 5 Univariate linear regression analysis of the parameters associated with absolute values of Alx

Covariates	β	t	β(95%CI)	P value
UAlb	6.201	2.977	2.065-10.337	< 0.004
Age	0.236	3.427	0.099-0.373	< 0.0001
BMI	0.036	0.667	0.070-0.142	0.507
pSBP	0.291	4.427	0.161-0.422	< 0.0001
pDBP	0.001	0.002	-0.216-0.216	< 0.002
pPP	0.278	4.536	0.156-0.400	< 0.0001
cSBP	0.349	5.518	0.223-0.474	< 0.0001
cDBP	-0.045	-0.401	0.265-0.176	0.689
cPP	0.265	4.912	0.558-0.372	< 0.0001
Ht	-0.848	0.002	-1.382-0.314	< 0.002
Hb	-0.599	-0.826	-2.040-0.841	0.411
T-CHOL	0.050	1.836	-0.041-0.042	0.069
TRG	0.021	1.164	0.015-0.057	0.247
HDL-C	0.104	1.318	-0.534-0.035	0.262
LDL-C	0.047	1.265	-0.045-0.052	0.243
Fbrinogen	0.007	0.749	-0.122-0.273	0.456
hsCRP	0.015	0.732	-1.738-3.768	0.466
RAAS-blocker	1.043	0.139	13.881-15.966	0.890

Table 6 Multivariate linear regression analysis of the parameters associated with the absolute values of Al

Covariates	β	t	β(95%CI)	P value
UAlb	4.385	2.557	1.023-8.146	< 0.012
cSBP	0.242	3.563	0.107-0.376	< 0.0001
cPP	0.147	2.623	0.036-0.259	< 0.0001
Ht	0.591	2.536	1.055-0.128	< 0.013

cSBP: Central systolic blood pressure; cPP: Central pulse pressure; Ht: Haematocrit.

Citation: Kalaitzidis RG, Karasavvidou DP, Tatsioni A, Pappas K, Katatsis G, Liontos A, Elisaf MS. Albuminuria as a marker of arterial stiffness in chronic kidney disease patients. World J Nephrol 2015; 4(3): 406-414
URL: https://www.wjgnet.com/2220-6124/full/v4/i3/406.htm
DOI: https://dx.doi.org/10.5527/wjn.v4.i3.406